US FDA Says To Stop Using 2 Eye Drop Products Because Of Serious Health Risks

Maryland : Federal health regulators are warning consumers to immediately stop using two additional eye drop products because of potential bacterial or fungal contamination.

The Food and Drug Administration is advising people not to buy “Dr. Berne’s MSM Drops 5% Solution” and “LightEyez MSM Eye Drops – Eye Repair,” warning that they could pose a serious health risk, including vision- and life-threatening infections. The agency noted that it doesn’t know of anyone who has reported a problem due to the products.

The latest recalls follow a spate of FDA warnings earlier this year against using several eye drop brands linked to an outbreak of drug-resistant bacteria. The outbreak is linked to at least 4 deaths across 18 states and dozens of infections.

Dr. Berne’s Whole Health Products distributes Dr. Berne’s products, while LightEyez Limited is the distributor of Light Eyez products.

The FDA’s testing of the products found they were contaminated with microbes and were not sterile, which is required under the Federal Food, Drug and Cosmetic Act. Both products, which the agency said are unapproved and are being illegally marketed in the U.S., also contain methylsulfonylmethane (MSM) as an active ingredient, which is not approved in eye drop products.

“Using contaminated eye drops could result in minor to serious vision-threatening infection which could possibly progress to a life-threatening infection,” the FDA said.

Dr. Berne issued a voluntary recall of the Dr. Berne’s MSM Drops 5% Solution, while London-based LightEyez Limited has not responded to the FDA nor taken actions to protect consumers, according to the agency.

According to the FDA, LightEyez’s product was contaminated with Pseudomonas aeruginosa, a bacteria that can cause infections in the blood, lungs or other parts of the body. Health authorities think a drug-resistant variant of the bacteria is responsible for the deaths and other health problems tied to suspect eye drops.

Global Pharma Healthcare in February recalled all lots of its EzriCare and Delsam Pharma brands of “Artificial Tears Lubricant Eye Drops,” which it said could be contaminated with bacteria.

Related Posts

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

New Delhi: In a major crackdown on the sale of expired and substandard products, the Central Range team of Delhi Police Crime Branch has arrested one person and seized nearly…

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

Washington:  On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg